theMednetRegister

Neurology

Cardiac Electrophysiology   

Questions discussed in this category

What is the most updated consensus regarding the use of pill in the pocket oral anticoagulation in paroxysmal atrial fibrillation, and populations of patients who are most likely to be considered for enrollment in clinical trials?
Which DOAC(s) could be best suited for pill in the pocket anticoagulation RCTs?
3 Answers available
For which stroke patients, if any, do you recommend implantable loop recorder for long-term cardiac monitoring and why?
It seems clear that longer monitoring yields more AF detected. What is less clear to me is whether all ILR-detected AF is relevant and merits anticoag...
4 Answers available
When do you consider pacing in arrhythmogenic epilepsy?
2 Answers available
Do you consider bleeding risk in elderly, frail patients with atrial fibrillation to be similar for all NOACs?
In FRAIL-AF, participants were switched from VKA to dabigatran, rivaroxaban, apixaban, and edoxaban.
4 Answers available
How do you manage patients with atrial fibrillation having a thromboembolic infarct despite being on adequate anticoagulation?
Would you recommend left atrial appendage occlusion with or without continuing anticoagulation? In light of Maarse et al., JAMA Neurology 2024.
3 Answers available
Is a history of coronary artery disease and afib a contraindication to using donepezil?
How do you counsel patients about any potential risk?
1 Answer available
Can bleeding risk when switching from VKA treatment to a NOAC in frail, elderly patients be accurately compared if individual times in therapeutic range while on VKA treatment are not captured?
Individual times in the therapeutic range while on VKA treatment was not registered in FRAIL-AF.
2 Answers available
Do you think that home INR monitoring is a feasible option for elderly, frail patients with atrial fibrillation on VKA treatment, given variations in socioeconomic status and access to care?
2 Answers available


Papers discussed in this category

American heart journal, 2010-07
Cryptogenic Stroke and underlying Atrial Fibrillation (CRYSTAL AF): design and rationale.
Lancet, 2021 Aug 27
Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial.
Circulation, 2023 Aug 27
Safety of Switching from a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients with Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial.
J Am Coll Cardiol,
Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.
Journal of cardiovascular electrophysiology, 2016-03
Targeted Anticoagulation for Atrial Fibrillation Guided by Continuous Rhythm Assessment With an Insertable Cardiac Monitor: The Rhythm Evaluation for Anticoagulation With Continuous Monitoring (REACT.COM) Pilot Study.
Heart rhythm, 2018-11
Intermittent anticoagulation guided by continuous atrial fibrillation burden monitoring using dual-chamber pacemakers and implantable cardioverter-defibrillators: Results from the Tailored Anticoagulation for Non-Continuous Atrial Fibrillation (TACTIC-AF) pilot study.
The New England journal of medicine, 2013-11-28
Edoxaban versus warfarin in patients with atrial fibrillation.
Archives of internal medicine, 1995-07-10
Prevention of embolic events after cardioversion of atrial fibrillation. Current and evolving strategies.
The New England journal of medicine, 2001-05-10
Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation.
The New England journal of medicine, 2009-05-14
Effect of clopidogrel added to aspirin in patients with atrial fibrillation.
The New England journal of medicine, 2011-09-15
Apixaban versus warfarin in patients with atrial fibrillation.
Circulation, 2013-02-05
Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial.
European heart journal, 2018-08-21
Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial.
Heart rhythm, 2014 May 09
PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD).
The New England journal of medicine, 2019 Nov 14
Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation.
The New England journal of medicine, 2023 Aug 25
Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes.
The New England journal of medicine, 2023 Nov 12
Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation.
Journal of medicine and life, 2021 Sep-Oct
The economic burden of stroke: a systematic review of cost of illness studies.
Journal of the American College of Cardiology, 2024 May 19
Apixaban vs Aspirin According to CHADS-VASc Score in Subclinical Atrial Fibrillation: Insights From ARTESiA.
Arrhythmia & electrophysiology review, 2021 Jul
Impact of the Pattern of Atrial Fibrillation on Stroke Risk and Mortality.

Related Topics in Neurology

Copyright © 2025 theMednet
All Rights Reserved.